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Variants in the neuronal sodium channel gene SCN8A have been implicated in several neurological
disorders. Early infantile epileptic encephalopathy type 13 results from de novo gain-of-function
mutations that alter the biophysical properties of the channel. Complete loss-of-function vari-
ants of SCN8A have been identified in cases of isolated intellectual disability. We now report a
novel heterozygous SCN8A variant, p.Pro1719Arg, in a small pedigree with five family members
affected with autosomal dominant upper limb isolated myoclonus without seizures or cognitive
impairment. Functional analysis of the p.Pro1719Arg variant in transfected neuron-derived cells
demonstrated greatly reduced Nav1.6 channel activity without altered gating properties. Hypo-
morphic alleles of Scn8a in the mouse are known to result in similar movement disorders. This
study expands the phenotypic and functional spectrum of SCN8A variants to include inherited
nonepileptic isolatedmyoclonus. SCN8A can be considered as a candidate gene for isolatedmove-
ment disorders without seizures.
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The SCN8A gene (MIM# 600702) encodes the neuronal voltage-gated
sodium channel Nav1.6, which is localized at the axon initial segment
and functions in initiation and propagation of action potentials. Nav1.6
is also concentrated at nodes of Ranvier inmyelinated neurons, includ-
ing sciatic nerve, and is expressed at a high level in cerebellar Purkinje
cells. During the past 5 years, SCN8A has been found to have a major
role in sporadic epilepsy. De novo missense mutations of SCN8A have
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and nomodifications or adaptations aremade.
c© 2018 The Authors.HumanMutation published byWiley Periodicals, Inc.
been identified in more than 200 individuals with early-onset epilep-
tic encephalopathy (EIEE13; MIM# 614558). Approximately 25% of
affected individuals carry recurrentmutations, many of which occur at
CpGdinucleotides in arginine codons (Wagnon&Meisler, 2015). Func-
tional analysis has demonstrated that the most common mechanism
is gain-of-function alterations in biophysical properties of Nav1.6 that
result in neuronal hyperexcitability (Meisler et al., 2016; Veeramah
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F IGURE 1 Inheritanceof the SCN8A variantP1719R in a familywith essentialmyoclonus.A: Pedigreedemonstrating coinheritanceofmyoclonus
and the SCN8A variant (c. 5156C>G, P1719R). Filled symbols, isolatedmyoclonus. B: Four-domain structure of the voltage-gated sodium channel
alpha subunit. P1719R is located in the pore loop of domain IV. C: Evolutionary conservation of residue P1719R in multiple species. h, human; m,
mouse; c, chicken; a, anole; z, zebrafish
et al., 2012). A small number of inherited variants have been associated
with less severe conditions, including benign familial infantile seizures
accompanied by paroxysmal dyskinesia (BFIS5,MIM#617080) (Anand
et al., 2016; Butler et al., 2017; Gardella et al., 2016; Han, Jang,
Lee, Shin, & Park, 2017). Heterozygous loss-of-function mutations of
SCN8A have been associated with isolated cognitive impairment in
two individuals with de novo mutations (Wagnon et al., 2017) and one
family with the protein truncation variant p.Pro1719Argfs*6 (MIM#
614306). In the mouse, homozygosity for partial loss-of-function alle-
les of Scn8a results in movement disorders including ataxia, tremor,
and dystonia, whereas homozygosity for null alleles results in paral-
ysis and juvenile lethality (Kearney et al., 2002; O'Brien & Meisler,
2013).
We now describe a missense variant of SCN8A in a family with
nonepileptic essential myoclonus. The proband is a 35-year-old
female with onset of isolated myoclonus at age 5 (Figure 1A, II-2).
She was diagnosed with upper limb action-induced nonepileptic
myoclonus, part of themyoclonus-dystonia spectrum (MIM# 159900).
The myoclonus is alcohol-responsive in this individual. The proband
has normal cognition and no other neurological abnormalities includ-
ing dystonic posturing. Her affected nephew (Figure 1A, III-2) is a 7-
year-old male with onset of action-induced myoclonus in the upper
limbs at age 4, and evidence of subcortical origin from electrophys-
iological studies. EMG recordings in the upper limbs showed irreg-
ular, multifocal, myoclonic bursts, with duration ranging from 50 to
200 msec. Myoclonic jerk frequency was increased with maintenance
of a postureorwith action. EEGback-averagingdid not reveal a cortical
correlate. His motor milestones were delayed, for example, indepen-
dent walking at age three, but he does not have intellectual disability
and does not exhibit dystonia or other neurological abnormalities. The
clinical features of these two family members are summarized in Sup-
plemental Table 1. Three additional family members were reported as
affected by a similar movement disorder (Figure 1A, I-2, II-3, and III-1),
but were not examined directly. The pedigree is consistent with auto-
somal dominant inheritance.
In order to identify the genetic basis for the disorder, we performed
whole-exome sequencing (WES) in individuals II-2 and III-2. The study
was approved by the University College London ethics committee
(UCLH project 06/N076), and written informed consent was obtained
from all participating subjects. DNA was extracted from peripheral
lymphocytes following a standard protocol. Point mutations and copy-
number variants in SGCE, the most common genetic cause of autoso-
mal dominant myoclonus-dystonia (MIM# 159900), were previously
excluded (Carecchio et al., 2013).
WES was carried out at the Institute of Neurology, University Col-
lege London, using Illumina, (Santa Clara, CA, USA)Nextera RapidCap-
ture according to the manufacturer's recommendations. Indexed and
pooled libraries were sequenced on Illumina's HiSeq3000. Bioinfor-
matic analysis was performed as previously described (Mencacci et al.,
2015).
Synonymous and noncoding variants were excluded from further
examination. Variants were filtered to include only those that were
shared by the two affected individuals and absent from public genomic
databases (dbSNP 137, 1000 Genomes project, NHLBI Exome Vari-
ant Server, Complete Genomics 69 and Exome Aggregation Consor-
tium [ExAC]). Finally, variants were required to have a CADD score
greater than 20, indicative of greater potential for pathogenicity
(https://cadd.gs.washington.edu/info) (Kircher et al., 2014).
After filtering, 11 variants remained (Supplemental Table 2). Among
these, SCN8A is the only gene with previous association with move-
ment disorders and a high intolerance score for missense and loss-
of-function variants (z = 7.7 and pLI = 1.0) (exac.broadinstitute.org).
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F IGURE 2 The SCN8A variant P1719R results in partial loss of Nav1.6 function. A: Representative traces of sodium currents recorded from
ND7/23 cells that were transfected with Nav1.6 cDNA. Black, wild-type (WT); red, P1719R. B: Averaged current–voltage (I–V) relation for WT
(black, n = 9) and P1719R (red, n = 9) channels, and nontransfected cells (purple, n = 12). C: Voltage dependence of channel activation. Smooth
lines correspond to the least squares fit when average data were fit to a single Boltzmann equation. D: Scatter plot of voltage at half-maximal
activation (V1/2) for cells expressingWTand P1719R channels. E: Voltage dependence of steady-state inactivation. Smooth lines correspond to the
least squares fit when average data were fit to a single Boltzmann equation. F: Scatter plot of voltage at half-maximal inactivation (V1/2) for cells
expressingWT and P1719R channels
Sanger sequencing analysis showed that the SCN8Amutation was also
present in individual III-1 (Figure 1A).
Affected individuals areheterozygous for the single nucleotide vari-
ant c.5156C > G in the SCN8A gene (RefSeq NM_014191.3), result-
ing in the amino acid substitution p.Pro1719Arg (P1719R). This vari-
ant is absent in ∼130,000 individuals listed in the gnomAD database
(https://gnomad.broadinstitute.org). Proline residue 1719 is located
in the pore loop of domain IV of the protein that confers sodium
selectivity to the channel (Figure 1B). The pore loops are highly con-
served through evolution and SCN8A residue 1719 is invariant in
vertebrate orthologs and the human paralogs SCN1A and SCN5A,
which diverged from SCN8A more than 400 million years ago (Fig-
ure 1C). Substitution of a charged arginine for the rigid proline
residue is a chemically nonconservative change likely to alter sec-
ondary structure of the channel protein. This variant has been sub-
mitted as entry # 00163785 to the locus specific public database
https://www.lovd.nl/SCN8A.
To determine experimentally whether P1719R is a deleterious vari-
ant, we carried out functional comparison of mutant and wildtype
Nav1.6. The substitutionP1719Rwas introduced into the tetrodotoxin
(TTX)-resistant derivativeof the full-lengthNav1.6 cDNAclone, as pre-
viously described (Wagnonet al., 2016). Site-directedmutagenesiswas
carried out with the QuikChange II XL kit (Agilent Technologies, Santa
Clara, CA, USA). The 6-kb open reading frame was re-sequenced to
confirm the absence of other mutations.
Channel activitywas characterized inDRG-neuronderivedND7/23
cells (Sigma–Aldrich, St. Louis, MO, USA). Cells were cultured and
transfected as previously described (Wagnon et al., 2016). Forty-eight
hours after transfection with 5 𝜇g of Nav1.6 alpha subunit cDNA and
0.5 𝜇g of the fluorescent m-Venus bioreporter, electrophysiological
recordings of fluorescent cells were made. Recording was carried out
in the presence of 500 nM TTX to block endogenous sodium cur-
rents. Currents were recorded using the whole-cell configuration of
the patch clamp recording technique as previously described (Wagnon
et al., 2016).
Cells expressing the Nav1.6-P1719R variant demonstrated inward
sodium current that was significantly reduced compared with cells
expressing wild-type channels: −27.3 ± 5.3 pA/pF (n = 9) for mutant
channel compared with −108 ± 21 pA/pF (n = 9) for wild-type
channel (P < 0.01) (Figure 2A and B). The voltage dependence of
mutant channel activation and inactivationdid not differ fromwildtype
(Figure 2C–F). The finding of partially reduced channel activity for
P1719R is novel, since previously characterized deleterious variants
resulted either in shifted voltage dependence of activation (Estacion
et al., 2014), delayed channel inactivation (Wagnon et al., 2016), or
complete loss of channel activity (Wagnon et al., 2017).
Individuals with epileptic encephalopathy due to gain-of-function
mutations of SCN8A often exhibit movement disorders and other neu-
rological signs such as hypotonia, ataxia, dystonia, hyperreflexia, and
choreoathetosis (Meisler et al., 2016). Severe hypotonia in these indi-
viduals is responsible for loss of intentional movement in 50% of
cases (Meisler et al., 2016). SCN8A variants have not been previ-
ously reported in individuals with isolated movement disorders. This
absence may reflect the lack of sequencing data in this population or
the failure to recognize the relevance of missense variants. The iden-
tification of SCN8A-P1719R cosegregating with isolated nonepileptic
myoclonus demonstrates thatmutation of SCN8A can result in isolated
movement disorders in patients.
Variants of SCN8Awith gain-of-function andelevated channel activ-
ity, either due to premature channel opening or delayed channel
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closing, result in epileptic encephalopathy (Meisler et al., 2016). At
the other extreme, heterozygosity for complete loss-of-function alle-
les of SCN8A can result in isolated intellectual disability (Trudeau,
Dalton, Day, Ranum, & Meisler, 2006; Wagnon et al., 2017). In rare
cases, seizures have been seen in individuals with loss-of-function
alleles of SCN8A lacking residual activity (Blanchard et al., 2015;
Moller et al., 2016). Partial loss-of-function with residual activity, as
demonstrated here for P1719R, has not previously been described
for a pathogenic variant of human SCN8A. The dominant pheno-
type of this pore loop mutation could result from impaired traffick-
ing of the coexpressed wild-type Nav1.6, possible because of the
recently described dimerization of the 𝛼 subunit (Clatot et al, 2017).
As another possibility, this mutation could impair glycosylation or
trafficking of the channel protein (e.g., Jones et al., 2016). The data
presented here demonstrate that heterozygosity for partial loss-of-
functionof SCN8A canbe associatedwithmovement disorderswithout
seizures.
In the mouse, homozygosity for the hypomorphic Scn8amedJ allele,
a splice site variant with 90% reduction in Nav1.6 protein, results
in severe progressive dystonia (Sprunger, Escayg, Tallaksen-Greene,
Albin, & Meisler, 1999). A second hypomorphic allele, Scn8a9J, results
in early onset tremor and adult onset dystonia (Jones et al., 2016).
Complete loss of mouse Scn8a associated with homozygosity for a
null allele results in hind limb paralysis and death (Burgess et al.,
1995). Conditional inactivation of Scn8a restricted to cerebellar Purk-
inje and granule layer neurons also leads to pronounced ataxia (Levin
et al., 2006), and dysfunction of cerebellar neurons could contribute
to myoclonus in the family described here. Cerebellar dysfunction has
been implicated in the pathogenesis of other forms of nonepileptic
myoclonus such as SGCE-related myoclonus-dystonia (Carbon et al.,
2013; Hubsch et al., 2011). Furthermore, we observed improvement
of myoclonus with alcohol intake in the adult subject with SCN8A-
P1719R, an effect likely to occur through modulation of the activity of
cerebellar neurons.
Three affected family members were demonstrated to carry the
SCN8A variant. A fourth affected family member, II-3, is an obli-
gate carrier since his sister and son carry the variant. The fifth
affected individual, III-1, who was not available for testing, is likely
to carry this variant since her clinical symptoms correspond to the
other four affected family members. SCN8A-P1719R thus appears
to be a fully penetrant pathogenic variant responsible for autoso-
mal dominant isolated myoclonus in this family, with no evidence
of maternal imprinting as observed in myoclonus dystonia due to
mutations of SGCE. In distinction from SGCF-related myoclonus dys-
tonia, the disease course in affected individuals from our kindred
seems to be nonprogressive and no relevant psychiatric disturbances
were observed. However other features (i.e., childhood-onset, dis-
tribution of symptoms in the upper part of the body, response to
alcohol, and a subcortical origin of myoclonus), partially overlap with
the clinical phenotype associated with mutations of SGCE, which
is generally dominated by myoclonus accompanied by mild dysto-
nia. These findings extend the phenotypic spectrum associated with
SCN8A to include amovement disorderwithout seizures or intellectual
disability.
ACKNOWLEDGMENT
The genetic study was undertaken at University College London Hos-
pitals and University College London (UCL), who receive support from
the Department of Health's National Institute for Health Research
(NIHR) Biomedical Research Centers funding streams.
DISCLOSURE STATEMENT




Anand, G., Collett-White, F., Orsini, A., Thomas, S., Jayapal, S., Trump, N.,
… Jayawant, S. (2016). Autosomal dominant SCN8A mutation with
an unusually mild phenotype. European Journal of Paediatric Neurology,
20(5)761–765. https://doi.org/10.1016/j.ejpn.2016.04.015
Blanchard, M. G., Willemsen, M. H.,Walker, J. B., Dib-Hajj, S. D., Waxman, S.
G., Jongmans, M. C.,…Kamsteeg, E. J. (2015). De novo gain-of-function
and loss-of-function mutations of SCN8A in patients with intellectual
disabilities and epilepsy. Journal of Medical Genetics, 52(5), 330–337.
https://doi.org/10.1136/jmedgenet-2014-102813
Burgess, D. L., Kohrman, D. C., Galt, J., Plummer, N. W., Jones, J. M., Spear,
B., & Meisler, M. H. (1995). Mutation of a new sodium channel gene,
Scn8a, in the mouse mutant ‘motor endplate disease’. Nature Genetics,
10(4), 461–465. https://doi.org/10.1038/ng0895-461
Butler, K. M., da Silva, C., Shafir, Y., Weisfeld-Adams, J. D., Alexander, J. J.,
Hegde, M., & Escayg, A. (2017). De novo and inherited SCN8A epilepsy
mutations detected by gene panel analysis. Epilepsy Research, 129, 17–
25. https://doi.org/10.1016/j.eplepsyres.2016.11.002
Carbon, M., Raymond, D., Ozelius, L., Saunders-Pullman, R., Frucht,
S., Dhawan, V., … Eidelberg, D. (2013). Metabolic changes
in DYT11 myoclonus-dystonia. Neurology, 80(4), 385–391.
https://doi.org/10.1212/WNL.0b013e31827f0798
Carecchio, M., Magliozzi, M., Copetti, M., Ferraris, A., Bernardini, L.,
Bonetti, M., … Valente, E. M. (2013). Defining the epsilon-sarcoglycan
(SGCE) gene phenotypic signature in myoclonus-dystonia: A reap-
praisal of genetic testing criteria. Movement Disorders, 28(6), 787–794.
https://doi.org/10.1002/mds.25506
Clatot, J., Hoshi, M., Wan, X., Liu, H., Jain, A., Shinlapawittayatorn,
K., … Deschenes, I. (2017). Voltage-gated sodium channels
assemble and gate as dimers. Nature Communications, 8(1), 2077.
https://doi.org/10.1038/s41467-017-02262-0
Estacion, M., O'Brien, J. E., Conravey, A., Hammer, M. F., Waxman, S.
G., Dib-Hajj, S. D., & Meisler, M. H. (2014). A novel de novo muta-
tion of SCN8A (Nav1.6) with enhanced channel activation in a child
with epileptic encephalopathy. Neurobiology of Disease, 69, 117–123.
https://doi.org/10.1016/j.nbd.2014.05.017
Gardella, E., Becker, F.,Moller, R. S., Schubert, J., Lemke, J. R., Larsen, L. H.,…
Weber, Y. G. (2016). Benign infantile seizures and paroxysmal dyskine-
sia caused by an SCN8Amutation. Annals of Neurology, 79(3), 428–436.
https://doi.org/10.1002/ana.24580
Han, J. Y., Jang, J. H., Lee, I. G., Shin, S., & Park, J. (2017). A novel inher-
itedmutation of SCN8A in a Korean family with benign familial infantile
epilepsy using diagnostic exome sequencing. Annals of Clinical and Labo-
ratory Science, 47(6), 747–753.
Hubsch, C., Vidailhet, M., Rivaud-Pechoux, S., Pouget, P., Brochard, V.,
Degos, B., … Roze, E. (2011). Impaired saccadic adaptation in DYT11
WAGNON ET AL. 969
dystonia. Journal of Neurology, Neurosurgery, and Psychiatry, 82(10),
1103–1106. https://doi.org/10.1136/jnnp.2010.232793
Jones, J. M., Dionne, L., Dell'Orco, J., Parent, R., Krueger, J. N., Cheng, X.,
…Meisler, M. H. (2016). Single amino acid deletion in transmembrane
segment D4S6 of sodium channel Scn8a (Nav1.6) in a mouse mutant
with a chronic movement disorder. Neurobiology of Disease, 89, 36–45.
https://doi.org/10.1016/j.nbd.2016.01.018
Kearney, J. A., Buchner, D. A., DeHaan, G., Adamska,M., Levin, S. I., Furay, A.
R.,…Meisler,M.H. (2002).Molecular andpathological effects of amod-
ifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Human
Molecular Genetics, 11(22), 2765–2775.
Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., &
Shendure, J. (2014). A general framework for estimating the relative
pathogenicity of human genetic variants. Nature Genetics, 46(3), 310–
315. https://doi.org/10.1038/ng.2892
Levin, S. I., Khaliq, Z. M., Aman, T. K., Grieco, T. M., Kearney, J. A., Raman, I.
M., & Meisler, M. H. (2006). Impaired motor function in mice with cell-
specific knockout of sodium channel Scn8a (NaV1.6) in cerebellar purk-
inje neurons and granule cells. Journal of Neurophysiology, 96(2), 785–
793. https://doi.org/10.1152/jn.01193.2005
Meisler, M. H., Helman, G., Hammer, M. F., Fureman, B. E., Gaillard,
W. D., Goldin, A. L., … Scheffer, I. E. (2016). SCN8A encephalopa-
thy: Research progress and prospects. Epilepsia, 57(7), 1027–1035.
https://doi.org/10.1111/epi.13422
Mencacci, N. E., Rubio-Agusti, I., Zdebik, A., Asmus, F., Ludt-
mann, M. H., Ryten, M., … Wood, N. W. (2015). A missense
mutation in KCTD17 causes autosomal dominant myoclonus-
dystonia. American Journal of Human Genetics, 96(6), 938–947.
https://doi.org/10.1016/j.ajhg.2015.04.008
Moller, R. S., Larsen, L. H., Johannesen, K. M., Talvik, I., Talvik, T.,
Vaher, U., … Dahl, H. A. (2016). Gene panel testing in epileptic
encephalopathies and familial epilepsies. Molecular Syndromology, 7(4),
210–219. https://doi.org/10.1159/000448369
O'Brien, J. E., & Meisler, M. H. (2013). Sodium channel SCN8A (Nav1.6):
Properties and de novo mutations in epileptic encephalopa-
thy and intellectual disability. Frontiers in Genetics, 4, 213.
https://doi.org/10.3389/fgene.2013.00213
Sprunger, L. K., Escayg, A., Tallaksen-Greene, S., Albin, R. L., & Meisler, M.
H. (1999). Dystonia associated with mutation of the neuronal sodium
channel Scn8a and identification of the modifier locus Scnm1 onmouse
chromosome 3.HumanMolecular Genetics, 8(3), 471–479.
Trudeau, M. M., Dalton, J. C., Day, J. W., Ranum, L. P., & Meisler,
M. H. (2006). Heterozygosity for a protein truncation mutation of
sodium channel SCN8A in a patient with cerebellar atrophy, ataxia,
and mental retardation. Journal of Medical Genetics, 43(6), 527–530.
https://doi.org/10.1136/jmg.2005.035667
Veeramah, K. R., O'Brien, J. E., Meisler, M. H., Cheng, X., Dib-Hajj, S.
D., Waxman, S. G., … Hammer, M. F. (2012). De novo pathogenic
SCN8A mutation identified by whole-genome sequencing of a
family quartet affected by infantile epileptic encephalopathy
and SUDEP. American Journal of Human Genetics, 90(3), 502–510.
https://doi.org/10.1016/j.ajhg.2012.01.006
Wagnon, J. L., Barker, B. S., Hounshell, J. A., Haaxma, C. A., Shealy, A.,
Moss, T., … Meisler, M. H. (2016). Pathogenic mechanism of recur-
rent mutations of SCN8A in epileptic encephalopathy. Annals of Clini-
cal and Translational Neurology, 3(2), 114–123. https://doi.org/10.1002/
acn3.276
Wagnon, J. L., Barker, B. S., Ottolini, M., Park, Y., Volkheimer, A., Valdez,
P., … Meisler, M. H. (2017). Loss-of-function variants of SCN8A in
intellectual disability without seizures. Neurology Genetics, 3(4), e170.
https://doi.org/10.1212/NXG.0000000000000170
Wagnon, J. L., & Meisler, M. H. (2015). Recurrent and non-recurrent muta-
tions of SCN8A in epileptic encephalopathy. Frontiers in Neurology, 6,
104. https://doi.org/10.3389/fneur.2015.00104
SUPPORTING INFORMATION
Additional supporting informationmay be found online in the Support-
ing Information section at the end of the article.
How to cite this article: Wagnon JL, Mencacci NE, Barker
BS, et al. Partial loss-of-function of sodium channel SCN8A
in familial isolated myoclonus. Human Mutation. 2018;39:965–
969. https://doi.org/10.1002/humu.23547
